| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |